These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11066156)

  • 1. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.
    Hoffman JP
    Ann Surg; 2000 Nov; 232(5):726-7. PubMed ID: 11066156
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.
    Evans DB; Wolff RA; Hess KR
    Ann Surg; 2000 Nov; 232(5):727. PubMed ID: 11066157
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant therapy for pancreatic and periampullary cancer.
    Tandon V
    Trop Gastroenterol; 2000; 21(3):129-30. PubMed ID: 11084835
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
    Klinkenbijl JH; Jeekel J; Sahmoud T; van Pel R; Couvreur ML; Veenhof CH; Arnaud JP; Gonzalez DG; de Wit LT; Hennipman A; Wils J
    Ann Surg; 1999 Dec; 230(6):776-82; discussion 782-4. PubMed ID: 10615932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer.
    Garofalo MC; Regine WF; Tan MT
    Ann Surg; 2006 Aug; 244(2):332-3; author reply 333. PubMed ID: 16858208
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant therapy following surgery for periampullary and pancreatic cancers.
    Sonkar AA; Poston GJ
    Eur J Surg Oncol; 2004 Nov; 30(9):911-2. PubMed ID: 15498632
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adjuvant therapy in the management of pancreatic cancer.
    Laheru D; Yeo CJ
    Adv Surg; 2005; 39():223-44. PubMed ID: 16250554
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of a patient with borderline resectable pancreatic cancer. Case report and review.
    Shah AP; Strauss JB; Leslie WT; Shah A; Mahon B; Abrams RA
    Oncology (Williston Park); 2008 Nov; 22(13):1524-9. PubMed ID: 19133606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiation for localized pancreatic cancer: another perspective.
    Evans DB; Abbruzzese JL
    Ann Surg Oncol; 1999; 6(1):4-7. PubMed ID: 10030405
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant therapy for surgically resected pancreatic adenocarcinoma.
    Abbruzzese JL
    JAMA; 2008 Mar; 299(9):1066-7. PubMed ID: 18319419
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant therapy in pancreatic cancer: a critical appraisal.
    Oettle H; Neuhaus P
    Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
    Abrams RA; Yeo CJ
    Surg Oncol Clin N Am; 2004 Oct; 13(4):621-38, ix. PubMed ID: 15350938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy.
    Cooperman AM; Snady H; Bruckner HW; Hammerman H; Siegel J; Stark B; Bank S
    Surg Clin North Am; 2001 Jun; 81(3):699-708. PubMed ID: 11459283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of pancreatic and periampullary collision cancers.
    Niu GM; Jin DY; Ji Y; Hou J; Wang DS; Lou WH
    J Dig Dis; 2010 Aug; 11(4):231-6. PubMed ID: 20649736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the body and tail of the pancreas: is there room for adjuvant radiotherapy?
    Coquard R; Ayzac L; Romestaing P; Ardiet JM; Sentenac I; Gilly FN; Braillon G; Gérard JP
    Tumori; 1997; 83(4):740-2. PubMed ID: 9349313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for pancreatic cancer.
    Morris SL; Beasley M; Leslie M
    N Engl J Med; 2004 Jun; 350(26):2713-5; author reply 2713-5. PubMed ID: 15215490
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy for pancreatic cancer.
    Bydder S; Spry N
    N Engl J Med; 2004 Jun; 350(26):2713-5; author reply 2713-5. PubMed ID: 15218576
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of radiotherapy in the multidisciplinary approach to pancreatic adenocarcinoma].
    Collette M
    Rev Med Liege; 2000 Mar; 55(3):141-5. PubMed ID: 10823001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.